Vivien D, Galéra P, Lebrun E, Loyau G, Pujol J P
Laboratoire de Biochimie du Tissu Conjonctif, CHU Côte de Nacre, Caen, France.
J Cell Physiol. 1990 Jun;143(3):534-45. doi: 10.1002/jcp.1041430319.
We examined the effect of transforming growth factor (TGF-beta) on the proliferative rate and cell cycle of cultured rabbit articular chondrocytes using cell counting, cytofluorometry, and [3H]-thymidine incorporation. In the presence of 2% or 10% FCS (fetal calf serum), TGF-beta at 0.01, 0.1, 1, and 10 ng/ml had an inhibitory effect on cell proliferation after 24 h exposure with a dose dependence only for 2% FCS. Flow cytometric analysis of cell DNA content at that time showed that a high proportion of cells were arrested in late S-phase (SQ or G2Q) in either 2% or 10% FCS-containing medium. In both cases, a disappearance of the cell blockage occurred between 24 and 48 h after TGF-beta addition. However, whereas a stimulation of cell proliferation rate was observed at that time in cultures containing 10% FCS, a dose-dependence inhibition of cell growth was detected, in contrast, for 2% FCS-treated cells. Presence of TGF-beta during the last 24 h was not necessary to release the arrested cells. Furthermore, platelet-poor plasma at 10% produced the same effects as FCS, suggesting that platelet-derived factors, such as platelet-derived growth factor (PDGF), could not be responsible for the release of blocked cells in this case. We compared the effect of TGF-beta to that of epidermal growth factor (EGF), used at an optimal concentration (10 ng/ml). In both slowly growing (2% FCS) and proliferating chondrocytes (10% FCS), EGF caused a significant increase of cell proliferation as early as 24 h. No arrest in late S-phase but an augmentation of the percentage of cells in S- and G2M-phases were observed. When combined, TGF-beta and EGF did not induce synergistic effect on the chondrocyte proliferation, as estimated by cell counting. [3H]-thymidine labeling showed that the factors induced identical maxima of incorporation but the peak occurred earlier for TGF-beta than for EGF (approximately 6 h versus 12 h, respectively). Although both factors induce similar cell-number increases at 48 h in 10% FCS-containing medium, these proliferative effects were due to different actions on the cell cycle. The present study indicates that TGF-beta induces first a recruitment of chondrocytes in noncycling SQ- or G2Q-blocked cells. The, the release of these cells may produce either apparent stimulation of cell proliferation if sufficient levels of an unknown serum factor are present (10% FCS) or an inhibition of growth rate when only reduced amounts of this factor are available (2% FCS).(ABSTRACT TRUNCATED AT 400 WORDS)
我们运用细胞计数、细胞荧光测定法以及[3H] - 胸腺嘧啶核苷掺入法,研究了转化生长因子(TGF - β)对培养的兔关节软骨细胞增殖速率和细胞周期的影响。在含有2%或10%胎牛血清(FCS)的情况下,0.01、0.1、1和10 ng/ml的TGF - β在暴露24小时后对细胞增殖具有抑制作用,且仅在2% FCS时呈剂量依赖性。此时对细胞DNA含量进行流式细胞术分析表明,在含有2%或10% FCS的培养基中,高比例的细胞停滞于S期晚期(SQ或G2Q)。在这两种情况下,添加TGF - β后24至48小时之间细胞阻滞消失。然而,在含有10% FCS的培养物中此时观察到细胞增殖速率受到刺激,相比之下,对于经2% FCS处理的细胞则检测到细胞生长的剂量依赖性抑制。在最后24小时存在TGF - β并非释放停滞细胞所必需。此外,10%的贫血小板血浆产生的效果与FCS相同,这表明在这种情况下,血小板衍生因子,如血小板衍生生长因子(PDGF),并非导致阻滞细胞释放的原因。我们将TGF - β的作用与以最佳浓度(10 ng/ml)使用的表皮生长因子(EGF)的作用进行了比较。在生长缓慢的(2% FCS)和增殖的软骨细胞(10% FCS)中,EGF早在24小时就显著促进了细胞增殖。未观察到停滞于S期晚期,而是观察到S期和G2M期细胞百分比增加。通过细胞计数估计,当TGF - β和EGF联合使用时,对软骨细胞增殖未产生协同作用。[3H] - 胸腺嘧啶核苷标记显示,这两种因子诱导的掺入最大值相同,但TGF - β的峰值出现时间比EGF早(分别约为6小时和12小时)。尽管在含有10% FCS的培养基中48小时时两种因子诱导的细胞数量增加相似,但这些增殖作用是由于对细胞周期的不同作用。本研究表明,TGF - β首先诱导软骨细胞募集到非循环的SQ或G2Q阻滞细胞中。然后,如果存在足够水平的未知血清因子(10% FCS),这些细胞的释放可能导致细胞增殖的明显刺激,而当仅存在少量这种因子(2% FCS)时则导致生长速率抑制。(摘要截短为400字)